Cours XTL Biopharmaceuticals Ltd. TEL AVIV STOCK EXCHANGE
Actions
XTLB
IL0010854979
Recherche biotechnologique et médicale
CA 2021 | - | CA 2022 | - | Capitalisation | 6,36 M 23,89 M 5,79 M |
---|---|---|---|---|---|
Résultat net 2021 | - 0 0 | Résultat net 2022 | -1 M -3,75 M -910 k | VE / CA 2021 | - |
Trésorerie nette 2021 | 6,13 M 23 M 5,58 M | Trésorerie nette 2022 | 3,72 M 13,97 M 3,39 M | VE / CA 2022 | - |
PER 2021 |
39,2
x | PER 2022 |
-4,72
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 93,3% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/12/14 |
Itay Weinstein
DFI | Director of Finance/CFO | 52 | 01/01/99 |
Doron Turgeman
CHM | Chairman | 56 | 30/12/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/12/14 |
Director/Board Member | 56 | 29/01/20 | |
Director/Board Member | 53 | 01/04/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+2,42% | 42,75 Md | |
+47,70% | 41,61 Md | |
+11,98% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,08% | 25,49 Md | |
-22,60% | 18,12 Md | |
+30,65% | 12,24 Md | |
-1,90% | 11,76 Md | |
+9,24% | 11 Md |